KHAN NAJAT (CEO and President) sold 5.2% of their position (36.60K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $202.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/19/2025ACC: 0001601830-25-000131
DirectorOfficer· CEO and President
Since Feb 2026
-40.39K
Net shares
Net seller
$223.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
40.39K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−3.79K
Price / share
$5.64
Trade value
$21.37K
% of position
0.5%
8/15/2025
708.59K→704.80K
Class A Common Stock
Direct
Shares
−36.60K
Price / share
$5.52
Trade value
$202.17K
% of position
5.2%
8/18/2025
704.80K→668.20K
Total
Net shares
−40.39K
Net value
-$223.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/15/2025 | F · Tax Withholding | −3.79K | $5.64 | $21.37K | 0.5% | 708.59K | 704.80K |
| Class A Common Stock Direct | 8/18/2025 | S · Sale | −36.60K | $5.52 | $202.17K | 5.2% | 704.80K | 668.20K |
| Total | −40.39K | -$223.54K | ||||||
Derivative Transactions0
No derivative transactions reported